SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Latest Comments
  • So simply put, we have the NABP saying that all ph... »
  • The original Brustle decision was widely criticise... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    WHO, WTO, WIPO Heads Call For More Medical Innovation

    Published on 8 July 2013 @ 7:01 pm

    By for Intellectual Property Watch

    The leaders of three top international organisations in Geneva last week discussed synergies in public health and called for increased collaboration and creativity to move medical innovation out of its quagmire of inefficiency. The opening session was marked by the head of the World Health Organization urging stakeholders to develop mechanisms to separate drug prices from costs of research and development. And the head of the GAVI Alliance, in the keynote address, discussed how patent thickets could impede access to vaccines.

    The directors general of the WHO, World Trade Organization and World Intellectual Property Organization addressed the opening session of a joint symposium on Medical Innovation: Changing Business Models, held on 5 July. They presented their comments and evaluations of the current medical innovation landscape, providing different perspectives from health, intellectual property, and trade.

    This was the third installment in the series of joint technical symposia on public health, intellectual property and trade convened by the three agencies. It was a follow-up to a recent trilateral publication, Promoting Access to Medical Technologies and Innovation.

    The speech of WHO Director General Margaret Chan was perhaps the most critical of the current innovation system. She cited a “great mismatch” between big profit and saving lives, describing the drug discovery process as “inefficient”. She underscored the need for innovation, because in her 40 years of experience, she had “never seen a major breakthrough” without innovation. Chan also drew attention to the drying-up of the antibiotic drug pipeline by asking why pharmaceutical companies are not investing in antibiotics.

    Chan described the drug discovery problem as one of concern for all countries, not only developing ones. Chan said that there is a need to “deconstruct and divorce” prices of drugs from the cost of research and development, but that “divorce always costs money,” referring to the need to find financing in order to fill the gaps.

    Chan noted, however, that during the last discussions on the report of the consultative expert working group (CEWG, on alternative funding models for medical R&D), there was “little appetite for a mandatory financing system,” and that it might be more effective if better use is made of what exists already. Chan reiterated the need for balance in areas of medicine innovation.

    In the keynote address, GAVI Alliance CEO Seth Berkley explained how patents “go both ways” in terms of impeding access. He cited two examples of hepatitis C and human papilloma virus, wherein patents were and were not barriers to access, respectively. In the case of hepatitis c vaccines, Berkley said due to strong patent protection and high upfront royalty fees, “small companies couldn’t enter the space” for R&D, and thus the early work on hepatitis c vaccine was impeded because companies could not engage in the development process.

    Berkley said there is huge patent protection in vaccines now compared to the past. It will be interesting from GAVI’s perspective to get partners to engage in working together given the recent significant increase in patent filings. Berkley said that these “patent thickets” are a growing challenge for many new vaccines in the future.

    WIPO Director General Francis Gurry opened the session by saying intellectual property in its broadest sense “is about the whole way in which society produces, distributes, and consumes information and knowledge.”

    Gurry said the “emergence of organisational innovation has called for innovation in the way intellectual property is used.” He was positive in his outlook that intellectual property has responded well by adapting to the evolved relationships and structures of organisations. He added that intellectual property “is capable of being neutral and a flexible instrument for organising relationships all along the spectrum of the production, distribution and consumption of knowledge and information.”

    WTO Director General Pascal Lamy said that the intellectual property system has the capacity to contribute and respond to humanity and public health needs but that it remains “essential to rethink, diversify business strategies” in such a way that is “win-win” to achieve better health outcomes for all patients and to create more incentive for commercial sector.

    Lamy said the ultimate goal is to increase the system’s capacity to develop new medical technologies, especially for neglected diseases (those predominantly affecting poor populations and for which there is little market incentive for investment). Lamy pointed to the day’s symposium as an example of how to listen and learn from a wider base of expertise. “It’s possible to exploit the incredible wealth, diversity of experience which we have in Geneva” to change the way medical innovation is approached, he said.

    The last comment of the session was delivered by Chan, who cautioned stakeholders not to “empire-build,” and instead to take advantage of all organisations and agencies to move things “fast-forward, quickly, instead of squandering money.”

    Brittany Ngo is currently completing her Master’s in Health Policy and Global Health at the Yale School of Public Health and previously obtained a Bachelor’s of Arts in Economics from Georgetown University. Through her studies she has developed an interest in health-related intellectual property issues. She is a summer intern at Intellectual Property Watch.

    Brittany Ngo may be reached at info@ip-watch.ch.

     

    Comments

    1. Top 10 Weekly Patent & IP News Update - Article One Partners says:

      [...]  WHO, WTO, and WIPO Heads Call for More Medical Innovation – Intellectual Property Watch [...]

    2. “Trilateral” Symposium Addresses Topics Of Global Public Health And IP | Intellectual Property Watch says:

      [...] The trilateral event was opened by the heads of the three international agencies (IPW, Public Health, 8 July 2013). [...]

    3. Riaz Tayob says:

      These are politicians playing the media and the audience and should not be believed until they change their practice… Chan’s WHO “gave” the Innovation and Neglected Diseases report to BigPharma before civil society got it, WTO’s Lamy will not come straight out and defend poor countries rights to use flexibilities for access to medicines – both however will come out and defend US pig farmers in Mexico saying pork is safe to eat during the Swine Flu pandemic though, and WIPOs Gurry has a technical assistance team who results in protecting flexibilities in poor countries is just shocking to say the least – he (as an institution) is not interested in flexibilities for the poor… reporting on these people needs to be backed up by assessment of practice… otherwise we get caught up in media spin…


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

     

     
    Your IP address is 54.91.191.48